Human Molecular Genetics, 2001, Vol. 10, No. 4 415-421
© 2001 Oxford University Press
A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of CharcotMarieTooth disease
1INSERM U289, 2Fédération de Neurologie, 3Consultation de Génétique Médicale, Hôpital de la Salpêtrière, 47 Boulevard de lHôpital, Paris, France, 4Department of Preclinical Veterinary Sciences, University of Edinburgh, UK, 5Unité de Génétique Médicale, Faculté de Médecine, Université Saint Joseph, Beirut, Lebanon and 6Laboratoire de Génétique Moléculaire, Institut de Biologie, Montpellier, France
CharcotMarieTooth (CMT) disease is a heterogeneous group of inherited peripheral motor and sensory neuropathies characterized by chronic distal weakness with progressive muscular atrophy and sensory loss in the distal extremities. Inheritance can be autosomal dominant, X-linked or autosomal recessive (ARCMT). Recently, a locus responsible for a demyelinating form of ARCMT disease, named CMT4F, has been mapped on 19q13 in a large consanguineous Lebanese family. L- and S-periaxin are proteins of myelinating Schwann cells and homozygous periaxin-null mice display extensive demyelination of myelinated fibers in the peripheral nervous system, which suggests that the periaxin gene is a good candidate gene for an ARCMT disease. The human gene encoding the periaxins (PRX) was mapped to 19q13, in the CMT4F candidate interval. After characterizing the human PRX gene, we identified a nonsense R196X mutation in the Lebanese family which cosegregated with CMT. Histopathological and immunohistochemical analysis of a sural nerve biopsy of one patient revealed common features with the mouse mutant and the absence of L-periaxin from the myelin sheath. These data confirm the importance of the periaxin proteins to normal Schwann cell function and substantiate the utility of the periaxin-null mouse as a model of ARCMT disease.
+ These authors contributed equally to this work
§ To whom correspondence should be addressed. Tel: +33 1 42 16 22 07; Fax: +33 1 44 24 36 58; Email: guilbot@ccr.jussieu.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. A. Court, J. E. Hewitt, K. Davies, B. L. Patton, A. Uncini, L. Wrabetz, and M. L. Feltri A Laminin-2, Dystroglycan, Utrophin Axis Is Required for Compartmentalization and Elongation of Myelin Segments J. Neurosci., March 25, 2009; 29(12): 3908 - 3919. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Azzedine, N. Ravise, C. Verny, A. Gabreels-Festen, M. Lammens, D. Grid, J. M. Vallat, G. Durosier, J. Senderek, S. Nouioua, et al. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology, August 22, 2006; 67(4): 602 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, M. O. Velardez, X. Warot, Z.-X. Yu, S. J. Miller, D. Cros, and G. Corfas Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function. J. Neurosci., March 22, 2006; 26(12): 3079 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
A D. Sandre-Giovannoli, V Delague, T Hamadouche, M Chaouch, M Krahn, I Boccaccio, T Maisonobe, E Chouery, R Jabbour, S Atweh, et al. Homozygosity mapping of autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy (CMT4H) to a novel locus on chromosome 12p11.21-q13.11 J. Med. Genet., March 1, 2005; 42(3): 260 - 265. [Full Text] [PDF] |
||||
![]() |
Y. Parman, E. Battaloglu, I. Baris, B. Bilir, M. Poyraz, N. Bissar-Tadmouri, A. Williams, N. Ammar, E. Nelis, V. Timmerman, et al. Clinicopathological and genetic study of early-onset demyelinating neuropathy Brain, November 1, 2004; 127(11): 2540 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Di Maria, R Gulli, P Balestra, D Cassandrini, S Pigullo, L Doria-Lamba, M Bado, A Schenone, F Ajmar, P Mandich, et al. A novel mutation of GDAP1 associated with Charcot-Marie-Tooth disease in three Italian families: evidence for a founder effect J. Neurol. Neurosurg. Psychiatry, October 1, 2004; 75(10): 1495 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Runker, I. Kobsar, T. Fink, G. Loers, T. Tilling, P. Putthoff, C. Wessig, R. Martini, and M. Schachner Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder J. Cell Biol., May 24, 2004; 165(4): 565 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Previtali, A. Nodari, C. Taveggia, C. Pardini, G. Dina, A. Villa, L. Wrabetz, A. Quattrini, and M. L. Feltri Expression of Laminin Receptors in Schwann Cell Differentiation: Evidence for Distinct Roles J. Neurosci., July 2, 2003; 23(13): 5520 - 5530. [Abstract] [Full Text] [PDF] |
||||
![]() |
A De Sandre-Giovannoli, M Chaouch, I Boccaccio, R Bernard, V Delague, D Grid, J M Vallat, N Levy, and A Megarbane Phenotypic and genetic exploration of severe demyelinating and secondary axonal neuropathies resulting from GDAP1 nonsense and splicing mutations J. Med. Genet., July 1, 2003; 40(7): e87 - 87. [Full Text] [PDF] |
||||
![]() |
V. C. J. Wallace, D. F. Cottrell, P. J. Brophy, and S. M. Fleetwood-Walker Focal Lysolecithin-Induced Demyelination of Peripheral Afferents Results in Neuropathic Pain Behavior That Is Attenuated by Cannabinoids J. Neurosci., April 15, 2003; 23(8): 3221 - 3233. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Birouk, H. Azzedine, O. Dubourg, M.-P. Muriel, A. Benomar, T. Hamadouche, T. Maisonobe, R. Ouazzani, A. Brice, M. Yahyaoui, et al. Phenotypical Features of a Moroccan Family With Autosomal Recessive Charcot-Marie-Tooth Disease Associated With the S194X Mutation in the GDAP1 Gene Arch Neurol, April 1, 2003; 60(4): 598 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Senderek, C. Bergmann, V. T. Ramaekers, E. Nelis, G. Bernert, A. Makowski, S. Zuchner, P. De Jonghe, S. Rudnik-Schoneborn, K. Zerres, et al. Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy Brain, March 1, 2003; 126(3): 642 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hattori, M. Yamamoto, T. Yoshihara, H. Koike, M. Nakagawa, H. Yoshikawa, A. Ohnishi, K. Hayasaka, O. Onodera, M. Baba, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients Brain, January 1, 2003; 126(1): 134 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nelis, S. Erdem, P. Y.K. Van den Bergh, M.-C. Belpaire-Dethiou, C. Ceuterick, V. Van Gerwen, A. Cuesta, L. Pedrola, F. Palau, A. A.W.M. Gabreels-Festen, et al. Mutations in GDAP1: Autosomal recessive CMT with demyelination and axonopathy Neurology, December 24, 2002; 59(12): 1865 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bondurand, M. Girard, V. Pingault, N. Lemort, O. Dubourg, and M. Goossens Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10 Hum. Mol. Genet., November 1, 2001; 10(24): 2783 - 2795. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Scherer Myelination: some receptors required J. Cell Biol., January 7, 2002; 156(1): 13 - 16. [Abstract] [Full Text] [PDF] |
||||







